LISAN S PENG, MD
Dermatology at Campbell Ave, Tucson, AZ

License number
Arizona 40621
Category
Osteopathic Medicine
Type
Dermatology
Address
Address
1501 N Campbell Ave, Tucson, AZ 85724
Phone
(520) 694-8888
(520) 694-2565 (Fax)
(520) 874-3500

Personal information

See more information about LISAN S PENG at radaris.com
Name
Address
Phone
Lisan Peng
1438 Adams St, Tucson, AZ 85719
Lisan Shirley Peng, age 53
1438 E Adams St, Tucson, AZ 85719
(520) 559-0525
Lisan Shirley Peng, age 53
1460 E Paseo Del Zorro, Tucson, AZ 85718
Lisan Shirley Peng, age 53
2035 E Edison St, Tucson, AZ 85719
Lisan Shirley Peng, age 53
2225 E Hampton St, Tucson, AZ 85719
(520) 881-0259

Organization information

See more information about LISAN S PENG at bizstanding.com

Dr. Lisan S. Peng

3838 N Campbell Ave, Tucson, AZ 85724

Industry:
Dermatologist
Phone:
(520) 626-6033 (Phone)


Lisan S Peng MD

3838 N Campbell Ave, Tucson, AZ 85719

Categories:
Dermatology Physicians & Surgeons
Phone:
(520) 694-2873 (Phone)

Professional information

Lisan S Peng Photo 1

Dr. Lisan S Peng, Tucson AZ - MD (Doctor of Medicine)

Specialties:
Dermatology
Address:
Arizona Cancer Center
3838 N Campbell Ave, Tucson 85719
(520) 694-2873 (Phone)
Languages:
English
Hospitals:
Arizona Cancer Center
3838 N Campbell Ave, Tucson 85719
The University of Arizona Medical Center
1501 North Campbell Ave, Tucson 85724
Education:
Medical School
University of California At Los Angeles
Graduated: 1999


Lisan S Peng Photo 2

Lisan S Peng, Tucson AZ

Specialties:
Dermatologist
Address:
1501 N Campbell Ave, Tucson, AZ 85724


Lisan Peng Photo 3

Antibody Fusion Proteins: Effective Adjuvants Of Protein Vaccination

US Patent:
2003018, Oct 2, 2003
Filed:
Apr 5, 2002
Appl. No.:
10/118473
Inventors:
Manuel Penichet - Los Angeles CA, US
Jay Dela Cruz - Inglewood CA, US
Lisan Peng - Tuscon AZ, US
Sherie Morrison - Los Angeles CA, US
Assignee:
The Regents of the University of California
International Classification:
A61K039/395, C07K016/46, C07K014/52
US Classification:
530/351000, 530/391100, 424/085100, 424/178100
Abstract:
The present invention provides methods of use of various antibody-immunostimulant fusion proteins as adjuvants of antigenic protein vaccinations to elicit humoral and/or cellular immune responses in vaccinated subjects. Compositions which include these fusion proteins and innate and/or exogenous antigenic proteins are also provided.